title: Stability of dry coated solid dosage forms.
abstract: The dry coating process was evaluated in terms of storage stability investigating drug release and agglomeration tendency of the different coated oral dosage forms; hydroxypropyl methylcellulose acetate succinate (HPMCAS) was used with triethylcitrate (TEC) as plasticizer and acetylated monoglyceride (Myvacet) as wetting agent. Talc or colloidal silicon dioxide (Aerosil) was used as anti-tacking agents. In contrast to coating formulations consisting of HPMCAS and Myvacet all formulations containing TEC showed enteric resistance and no agglomeration tendency after preparation. After storage at 10% RH +/- 5% enteric resistance is increased slightly. This increase is more pronounced at 60% RH +/- 5%. The formulations without anti-tacking agents showed higher drug releases after 12 and 24 months due to the damage of the film's integrity during sample preparation caused by the high tackiness of the film. Tackiness is not affected by storing if samples are stored at low relative humidity. At high relative humidity tackiness increases upon storage especially for formulations without anti-tacking agents. The sieving results of the agglomeration measurements after storage can be confirmed by ring shear measurements performed immediately after preparation and approved to be a tool, which is able to predict the agglomeration during storage.
authors.affiliation: Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University Duesseldorf, Universitaetsstrasse 1, 40225 Duesseldorf, Germany.
authors.forename: Caroline Désirée
authors.initials: CD
authors.lastname: Kablitz
authors.forename: Nora Anne
authors.initials: NA
authors.lastname: Urbanetz
mesh_terms: D000268:Adhesiveness; D002626:Chemistry, Pharmaceutical; D002951:Citrates / Q000737:chemistry; D004304:Dosage Forms; D004339:Drug Compounding; D004355:Drug Stability; D006813:Humidity; D006863:Hydrogen-Ion Concentration; D008747:Methylcellulose / Q000031:analogs & derivatives / Q000737:chemistry; D050178:Monoglycerides / Q000737:chemistry; D011208:Powders / Q000737:chemistry; D012212:Rheology; D012822:Silicon Dioxide / Q000737:chemistry; D013608:Tablets, Enteric-Coated / Q000737:chemistry; D013627:Talc / Q000737:chemistry; D013696:Temperature; D013806:Theophylline / Q000008:administration & dosage / Q000737:chemistry
chemical_list: D002951:Citrates; D004304:Dosage Forms; D050178:Monoglycerides; D011208:Powders; D013608:Tablets, Enteric-Coated; D013627:Talc; C048331:hydroxypropylmethylcellulose acetate succinate; D012822:Silicon Dioxide; C023001:ethyl citrate; D008747:Methylcellulose; D013806:Theophylline